THINGS ARE LOOKING UP FOR MORE GAMES
OF FETCH

One key to your canine patients’ health is helping them stay active. Galliprant® (grapiprant tablets) delivers targeted, effective pain relief from the earliest diagnosed stages* of canine osteoarthritis (OA).1 This non-COX-inhibiting NSAID was proven effective in a placebo-controlled clinical study of 285 dogs.1

See how Galliprant’s mode of action can help you target canine OA pain and inflammation while reducing the impact on GI, kidney and liver homeostasis.2,3

*Treatment can be started in dogs as early as 9 months of age.
Golden
GOLDEN RETRIEVER mobile

THINGS ARE LOOKING UP FOR MORE GAMES
OF FETCH

One key to your canine patients’ health is helping them stay active. Galliprant® (grapiprant tablets) delivers targeted, effective pain relief from the earliest diagnosed stages* of canine osteoarthritis (OA).1 This non-COX-inhibiting NSAID was proven effective in a placebo-controlled clinical study of 285 dogs.1

See how Galliprant’s mode of action can help you target canine OA pain and inflammation while reducing the impact on GI, kidney and liver homeostasis.2,3

*Treatment can be started in dogs as early as 9 months of age.
Start The movement

When it comes to healthy dogs, movement is vital. Check out these new tools and ideas to help identify canine OA at its earliest stages and keep your canine patients moving.

Introducing COAST

coast2
A new standardized approach to staging dogs with OA to facilitate earlier detection of clinical and at-risk dogs.

Signs & Stages

time and pet
Discover how you can bridge the canine OA treatment gap.

Indication

Galliprant is an NSAID indicated for the control of pain and inflammation associated with osteoarthritis in dogs.

Important Safety Information

Not for use in humans. For use in dogs only. Keep this and all medications out of reach of children and pets. Store out of reach of dogs and other pets in a secured location in order to prevent accidental ingestion or overdose. Do not use in dogs that have a hypersensitivity to grapiprant. If Galliprant is used long term, appropriate monitoring is recommended. Concomitant use of Galliprant with other anti-inflammatory drugs, such as COX-inhibiting NSAIDs or corticosteroids, should be avoided. Concurrent use with other anti-inflammatory drugs or protein-bound drugs has not been studied. The safe use of Galliprant has not been evaluated in dogs younger than 9 months of age and less than 8 lbs (3.6 kg), dogs used for breeding, pregnant or lactating dogs, or dogs with cardiac disease. The most common adverse reactions were vomiting, diarrhea, decreased appetite, and lethargy. Click here for full prescribing information.